Stoke Therapeutics (STOK) Leases (2022 - 2025)
Historic Leases for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $3.7 million.
- Stoke Therapeutics' Leases fell 2475.65% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 2475.65%. This contributed to the annual value of $4.3 million for FY2024, which is 597.56% up from last year.
- Latest data reveals that Stoke Therapeutics reported Leases of $3.7 million as of Q3 2025, which was down 2475.65% from $3.2 million recorded in Q2 2025.
- Stoke Therapeutics' Leases' 5-year high stood at $6.1 million during Q1 2024, with a 5-year trough of $3.1 million in Q3 2023.
- In the last 4 years, Stoke Therapeutics' Leases had a median value of $4.3 million in 2024 and averaged $4.5 million.
- Its Leases has fluctuated over the past 5 years, first plummeted by 4175.64% in 2023, then surged by 5979.25% in 2024.
- Over the past 4 years, Stoke Therapeutics' Leases (Quarter) stood at $4.8 million in 2022, then decreased by 13.74% to $4.1 million in 2023, then grew by 5.98% to $4.3 million in 2024, then dropped by 14.66% to $3.7 million in 2025.
- Its Leases stands at $3.7 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.8 million for Q1 2025.